Teva Pharmaceutical Finance Netherlands III B.V.

Related Filers (10)

Other (7)

EFFECT
Monday, 8/17/2020
Notice of Effectiveness
CORRESP
Thursday, 8/13/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 8/13/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 4/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 4/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 4/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
POSASR
Wednesday, 7/13/2016
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Show More

Prospectus (12)

424B5
Thursday, 11/4/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Wednesday, 10/27/2021
Automatic shelf registration statement of securities of well-known seasoned issuers
424B3
Wednesday, 10/27/2021
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Monday, 8/17/2020
Prospectus filed pursuant to Rule 424(b)(3)
S-4
Wednesday, 8/5/2020
Registration of securities issued in business combination transactions
424B3
Thursday, 4/19/2018
Prospectus filed pursuant to Rule 424(b)(3)
S-4
Monday, 4/2/2018
Registration of securities issued in business combination transactions
S-3/A
Wednesday, 3/28/2018
Registration statement for specified transactions by certain issuers
S-3/A
Friday, 2/16/2018
Registration statement for specified transactions by certain issuers
S-3
Monday, 1/29/2018
Registration statement for specified transactions by certain issuers
424B5
Tuesday, 7/19/2016
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 7/18/2016
Prospectus filed pursuant to Rule 424(b)(5)
Show More